ADAP insider trading

Adaptimmune Therapeutics PLC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
264
Last 90 days
0
Buys / sells
39% / 53%
Market cap

ADAP insider activity at a glance

FilingIQ has scored 264 insider transactions for ADAP since Jan 18, 2016. The most recent filing in our index is dated Sep 2, 2025.

Across the full history, 103 open-market purchases and 139 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ADAP insider trades is 60.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest ADAP Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for ADAP?
FilingIQ tracks 264 Form 4 insider transactions for ADAP (Adaptimmune Therapeutics PLC), covering filings from Jan 18, 2016 onwards. 0 of those were filed in the last 90 days.
Are ADAP insiders net buyers or net sellers?
Across the full Form 4 history for ADAP, 103 transactions (39%) were open-market purchases and 139 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ADAP insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every ADAP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.